- Home
- CIM vs OCUL Comparison
CIM vs OCUL Comparison
Compare CIM & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIM
- OCUL
- Stock Information
- Founded
- CIM 2007
- OCUL 2006
- Country
- CIM United States
- OCUL United States
- Employees
- CIM N/A
- OCUL N/A
- Industry
- CIM Real Estate Investment Trusts
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- CIM Real Estate
- OCUL Health Care
- Exchange
- CIM Nasdaq
- OCUL Nasdaq
- Market Cap
- CIM 965.2M
- OCUL 957.3M
- IPO Year
- CIM 2007
- OCUL 2014
- Fundamental
- Price
- CIM $12.63
- OCUL $7.06
- Analyst Decision
- CIM Hold
- OCUL Strong Buy
- Analyst Count
- CIM 2
- OCUL 10
- Target Price
- CIM $16.00
- OCUL $16.11
- AVG Volume (30 Days)
- CIM 512.8K
- OCUL 1.6M
- Earning Date
- CIM 05-08-2025
- OCUL 05-05-2025
- Dividend Yield
- CIM 11.72%
- OCUL N/A
- EPS Growth
- CIM N/A
- OCUL N/A
- EPS
- CIM 1.52
- OCUL N/A
- Revenue
- CIM $326,755,000.00
- OCUL $59,647,000.00
- Revenue This Year
- CIM $11.59
- OCUL $13.32
- Revenue Next Year
- CIM $2.13
- OCUL $13.13
- P/E Ratio
- CIM $8.31
- OCUL N/A
- Revenue Growth
- CIM 11.90
- OCUL N/A
- 52 Week Low
- CIM $9.85
- OCUL $4.06
- 52 Week High
- CIM $16.89
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- CIM 57.02
- OCUL 44.18
- Support Level
- CIM $11.96
- OCUL $6.84
- Resistance Level
- CIM $13.28
- OCUL $8.90
- Average True Range (ATR)
- CIM 0.34
- OCUL 0.47
- MACD
- CIM 0.16
- OCUL -0.11
- Stochastic Oscillator
- CIM 67.73
- OCUL 10.71
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.